hOA-DN30

N/A

Report date: 2025/01/06 16:20:27

Base Information

Drug NamehOA-DN30
Drug Alias NamehOA-DN30DN 30
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Hepatocyte growth factor receptor
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetis Precision Medicine SB SRL
China Registration ClassN/A

Develop Information

Active CompaniesMetis Precision Medicine SB SRL
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A